🎁 Black Friday: up to 50% off of annual plans
Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
41.37
-2.28 (-5.22%)
At close: Nov 20, 2026, 4:00 PM EST
41.40
+0.03 (0.07%)
After-hours: Nov 20, 2026, 7:30 PM EST

Arrowhead Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Oct - Sep.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Cash & Equivalents
58.54224.6599.19102.99100.71
Short-Term Investments
1,130692.82578.28292.74268.39
Cash & Short-Term Investments
1,189917.47677.46395.73369.1
Cash Growth
29.57%35.43%71.19%7.22%0.36%
Receivables
32.176.82--1.41
Inventory
9.08----
Prepaid Expenses
31.5810.939.548.817.29
Restricted Cash
4.21.93.57.97.3
Other Current Assets
23.4113.524.974.0320.2
Total Current Assets
1,289950.64695.47416.47405.3
Property, Plant & Equipment
429.65426.41431.29335.56168.59
Long-Term Investments
0.01---105.87
Other Intangible Assets
5.166.868.5610.2611.96
Other Long-Term Assets
14.221.394.483.260.22
Total Assets
1,7381,3851,140765.55691.94

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Accounts Payable
30.1517.6711.3935.872.87
Accrued Expenses
136.1396.2480.843.6859.11
Short-Term Debt
6.8----
Current Portion of Long-Term Debt
4040---
Current Portion of Leases
5.57.296.3410.562.78
Current Income Taxes Payable
-20.8---
Current Unearned Revenue
91.652.4-0.8774.1
Other Current Liabilities
1.1111.094.6414.48-
Total Current Liabilities
311.34195.49103.17105.46138.85
Long-Term Debt
1,239582.28734.54268.33-
Long-Term Leases
115.81104.11111.03104.6178.8
Long-Term Unearned Revenue
21.34---55.95
Total Liabilities
1,688881.88948.74478.39273.6

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Common Stock
0.240.230.220.20.2
Additional Paid-In Capital
2,4622,1401,8061,3001,219
Retained Earnings
-2,351-1,627-1,626-1,026-820.76
Treasury Stock
-53.19-53.19---
Comprehensive Income & Other
-7.656.444.75-3.22-0.14
Total Common Equity
50.31466.05185.44271.34398.52
Minority Interest
0.1937.365.6215.8219.82
Shareholders' Equity
50.5503.42191.06287.16418.34
Total Liabilities & Equity
1,7381,3851,140765.55691.94

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Total Debt
1,407733.68851.91383.581.58
Net Cash (Debt)
-218.59183.79-174.4512.23287.52
Net Cash Growth
----95.75%-15.99%
Net Cash Per Share
-1.541.37-1.460.112.73
Filing Date Shares Outstanding
141.37135.81124.43107.43106.01
Total Common Shares Outstanding
141.29135.7124.38107.31105.96
Working Capital
977.88755.15592.3311.02266.45
Book Value Per Share
0.363.431.492.533.76
Tangible Book Value
45.15459.19176.88261.08386.56
Tangible Book Value Per Share
0.323.381.422.433.65
Land
33333
Buildings
256.56251.3275.99--
Machinery
105.778871.9358.7540.47
Construction In Progress
4.5215.94188.73166.6656.37
Leasehold Improvements
105.15104.43104.41103.8142.02
SEC Filings: 10-K · 10-Q